Literature DB >> 17442781

Pneumonic tularemia on Martha's Vineyard: clinical, epidemiologic, and ecological characteristics.

Bela T Matyas1, Henry S Nieder, Sam R Telford.   

Abstract

Martha's Vineyard, Massachusetts, is the site of the only two recognized outbreaks of primary pneumonic tularemia in the United States. Beginning in 2000 and continuing through 2006, 59 presumed or confirmed tularemia cases have been reported from Martha's Vineyard, with more than 60% of these presumed to be due to inhalation of the agent. A joint CDC/Massachusetts Department of Public Health case-control study identified landscaping activities such as lawnmowing or brush cutting to be important risk factors. The fomites that serve as the basis for risk for landscapers, however, remain unidentified. Clinically, cases generally have a pneumonic component, but the development of pulmonary signs can be greatly delayed. The spectrum of illness ranges from relatively mild disease, in which cases may be treated on an outpatient basis, to severe illness requiring hospitalization. In each scenario, gentamicin therapy tends to rapidly induce defervescence, although exceptions have been noted. Even with heightened awareness during the current outbreak, physicians may easily miss a diagnosis of tularemia, usually by attributing illness to the more common Febrile illnesses. Dog ticks appear to maintain the agent on this island, with as many as 5% infected by the agent of tularemia. The main hosts for dog ticks, skunks and raccoons, are very frequently seroreactive, suggesting the possibility for their involvement in environmental contamination due to their peridomestic habits. Why tularemia is prevalent on Martha's Vineyard and why it commonly presents as a pneumonic disease there remain undescribed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17442781     DOI: 10.1196/annals.1409.013

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  31 in total

1.  A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challenge.

Authors:  Qingmei Jia; Richard Bowen; Jacob Sahakian; Barbara Jane Dillon; Marcus A Horwitz
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

2.  Comparison of experimental respiratory tularemia in three nonhuman primate species.

Authors:  Audrey R Glynn; Derron A Alves; Ondraya Frick; Rebecca Erwin-Cohen; Aimee Porter; Sarah Norris; David Waag; Aysegul Nalca
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2015-02-07       Impact factor: 2.268

3.  A case of tularemia after an endurance run in a non-endemic region.

Authors:  R Meckenstock; A Therby; A Le Monnier; D Khau; S Monnier; B Pangon; A Greder-Belan
Journal:  Infection       Date:  2012-10-17       Impact factor: 3.553

Review 4.  Ecology of Francisella tularensis.

Authors:  Sam R Telford; Heidi K Goethert
Journal:  Annu Rev Entomol       Date:  2019-10-10       Impact factor: 19.686

5.  An unexpected cause for cavitary pneumonia and empyema.

Authors:  Constantine Bloch-Infanger; Katarzyna Furrer; Mark Wiese; Andreas Hiebinger; Christoph M Bucher; Sébastien Kopp; Vladimira Hinić; Daniel Goldenberger
Journal:  Infection       Date:  2015-11-30       Impact factor: 3.553

6.  Quantum of infection of Francisella tularensis tularensis in host-seeking Dermacentor variabilis.

Authors:  Heidi K Goethert; Sam R Telford
Journal:  Ticks Tick Borne Dis       Date:  2010-03       Impact factor: 3.744

7.  Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.

Authors:  Qingmei Jia; Richard Bowen; Bai-Yu Lee; Barbara Jane Dillon; Saša Masleša-Galić; Marcus A Horwitz
Journal:  Vaccine       Date:  2016-08-28       Impact factor: 3.641

8.  Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112.

Authors:  Joshua D Hall; Matthew D Woolard; Bronwyn M Gunn; Robin R Craven; Sharon Taft-Benz; Jeffrey A Frelinger; Thomas H Kawula
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

Review 9.  Vaccines against tularemia.

Authors:  Eileen M Barry; Leah E Cole; Araceli E Santiago
Journal:  Hum Vaccin       Date:  2009-12-11

10.  Metapopulation structure for perpetuation of Francisella tularensis tularensis.

Authors:  Heidi K Goethert; Benjamin Saviet; Sam R Telford
Journal:  BMC Microbiol       Date:  2009-07-23       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.